King Bio Aquaflora Phase II Candida Control Program Recall

Why it was recalled

Microbial contamination

Product description

Aquaflora Phase II Candida Control Program, Net 16 fl. oz. (1 PT) 473 mL, Homeopathic Formula, Manufactured by: King Bio, Inc. 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955160267, NDC 57955-1602-6

Lot numbers, UPCs & expiration codes

Lots: 010518G Exp. 07/18; 011617F Exp. 01/20; 021016G Exp. 02/19; 051716P Exp. 02/19; 072315A Exp. 07/18

Where it was sold

U.S.A. Nationwide, Canada, and Australia.

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0901-2019
Classification: Class I
Status: Terminated
Recall initiated: Jul 20, 2018
FDA report date: Mar 20, 2019
Quantity: 2248 bottles
Recall type: Voluntary: Firm initiated
Recalling firm: King Bio Inc.

Original FDA data

Every field from FDA enforcement report D-0901-2019, exactly as published.

Show all FDA fields

City: Asheville
State: NC
Status: Terminated
Country: United States
Event ID: 80601
Address: 3 Westside Dr
Code information: Lots: 010518G Exp. 07/18; 011617F Exp. 01/20; 021016G Exp. 02/19; 051716P Exp. 02/19; 072315A Exp. 07/18
Postal code: 28806-2846
Report date: Mar 20, 2019
Product type: Drugs
Recall number: D-0901-2019
Classification: Class I
Recalling firm: King Bio Inc.
Product quantity: 2248 bottles
Termination date: Jan 19, 2022
Reason for recall: Microbial contamination
Voluntary / mandated: Voluntary: Firm initiated
Product description: Aquaflora Phase II Candida Control Program, Net 16 fl. oz. (1 PT) 473 mL, Homeopathic Formula, Manufactured by: King Bio, Inc. 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955160267, NDC 57955-1602-6
Distribution pattern: U.S.A. Nationwide, Canada, and Australia.
Recall initiation date: Jul 20, 2018
Initial firm notification: Press Release
Center classification date: Mar 8, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0901-2019, published Mar 20, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.